News about Biotechnology

Two ImmunoINSIGHTS contracts signed by Oncimmune

Two ImmunoINSIGHTS contracts signed by Oncimmune

Oncimmune Holdings announces the signing of two new ImmunoINSIGHTS commercial contracts.

Biotechnology | 15/04/2022 | By Sudeep Soparkar

Global diseases treatment with mRNA to be researched by Moderna and IAVI together

Global diseases treatment with mRNA to be researched by Moderna and IAVI together

Moderna and IAVI, a nonprofit scientific research organization, are teaming up to use mRNA to develop new therapies for a range of diseases like HIV / AIDS, Tuberculosis, anti-microbial-resistant enteric infection and COVID-19.

Biotechnology | 12/04/2022 | By Sudeep Soparkar

The AI-designed protective betacoronavirus vaccine to be developed jointly by CEPI and Japan?s NEC Group

The AI-designed protective betacoronavirus vaccine to be developed jointly by CEPI and Japan?s NEC Group

CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation declared the most recent subsidizing grant under its US$ 200 million program to propel the improvement of antibodies that give wide assurance against SARS-CoV-2 variations and other betacoronaviruses.

Biotechnology | 09/04/2022 | By Sudeep Soparkar

Collaboration between ICMR and Pharma companies to develop Dengue vaccine

Collaboration between ICMR and Pharma companies to develop Dengue vaccine

With the rise in dengue cases across the country, the Indian Council of Medical Research (ICMR) has embarked on an initiative aiming to facilitate development of dengue vaccine. Vaccine manufacturer and pharma companies who have developed or have license of tetravalent dengue vaccine candidate and have successfully completed its phase I and phase II

Biotechnology | 07/03/2022 | By Darshana

Orphan Drug Designation offered by US FDA to BCMA CAR-T cell therapy co-developed by Innovent Biologics and IASO Bio

Orphan Drug Designation offered by US FDA to BCMA CAR-T cell therapy co-developed by Innovent Biologics and IASO Bio

The US Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has formally granted Orphan Drug Designation (ODD) to Innovent Biologics's fully-human B-Cell Maturation Antigen (BCMA)-targetted Chimeric Antigen Receptor (CAR) T-cell therapy

Biotechnology | 17/02/2022 | By Darshana

Proteon Pharma to develop bacteriophages as a sustainable alternative to antibiotics in poultry industry

Proteon Pharma to develop bacteriophages as a sustainable alternative to antibiotics in poultry industry

Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, announced it will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry

Biotechnology | 18/10/2021 | By Darshana 119

A study shows how AI technology on clinical decision system can help India in primary and secondary healthcare

A study shows how AI technology on clinical decision system can help India in primary and secondary healthcare

An integrated clinical decision support system (CDSS) using artificial intelligence (AI) could be useful to health workers in primary and secondary healthcare settings to overcome the present challenges including a lack of adequate manpower in the system, according to a study sponsored by NITI Aayog and UK-Department of International Trade

Biotechnology | 01/09/2021 | By Darshana

Nucleome unveils South Asia's largest genomics research centre in Hyderabad

Nucleome unveils South Asia's largest genomics research centre in Hyderabad

In a move that will mark the beginning of a new era in India's genomics capability, Nucleome Informatics has unveiled South Asia's largest and most advanced genomics facility, NKC Centre for Genomics Research in Hyderabad

Biotechnology | 27/08/2021 | By Darshana 123

Sana Biotech obtains non-exclusive clinical & commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform

Sana Biotech obtains non-exclusive clinical & commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform

MaxCyte, Inc., a leading provider of cell-engineering platform technologies, announced the signing of a clinical and commercial license with Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines.

Biotechnology | 10/08/2021 | By Darshana 112

Pharmexcil seeks list of products requiring SION norms fixation from exporters

Pharmexcil seeks list of products requiring SION norms fixation from exporters

The Pharmaceutical Export Promotion Council of India (Pharmexcil) has asked exporters to provide a list of products requiring Standard Input Output Norms (SION) fixation to help them fulfill export obligations in a timely manner

Biotechnology | 02/08/2021 | By Darshana 105

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology